G. Mendoza-Díaz et al.
ARTICLE
[3] K. D. Karlin, J. C. Hayes, S. Juen, J. P. Hutchison, J. Zubieta,
Inorg. Chem. 1982, 21, 4106.
[4] W. Kaim, J. Rall, Angew. Chem. Int. Ed. Engl. 1996, 35, 43.
[5] J. M. Gauss, P. R. Harrowell, M. M. Valerie, A. Norris, H. C.
Freeman, J. Mol. Biol. 1986, 192, 361.
[6] E. Bouwman, B. Douziech, L. Gutierrez-Soto, M. Beretta, W. L.
Driessen, J. Reedijk, G. Mendoza-Díaz, Inorg. Chim. Acta 2000,
304, 250.
[7] M. Ch. Mimmi, F. Minnichè, H. Kooijman, A. L. Spek, S. T. War-
zeska, E. Bouwman, Inorg. Chim. Acta 2002, 340, 197–200.
[8] W. L. Driessen, D. Rehorst, J. Reedijk, I. Mutikainen, U. Turp-
einen, Inorg. Chim. Acta 2003, 355, 64.
[9] M. Beretta, E. Bouwman, L. Casella, B. Douziech, W. L.
Driessen, L. Gutierrez-Soto, E. Manzani, J. Reedijk, Inorg. Chim.
Acta 2000, 310, 41.
[10] W. Wehrli, F. Knusel, K. Schmid, M. Staehelin, Proc. Natl. Acad.
Sci. USA 1968, 65, 667–673.
[11] D. J. Jin, M. Cashel, D. I. Friedman, Y. Nakamaru, W. A. Walter,
C. A. Gross, J. Mol. Biol. 1988, 204, 247–261.
Figure 6. Frequency of production of colonies resistant to rifampicin
of cultures of strain B. subtilis PERM115 supplemented or not with
the complex [Cu(biaq)Cl2] or the ligand biaq.
[12] K. Severinov, M. Soushko, A. Goldfarb, V. Nikiforov, J. Biol.
Chem. 1993, 268, 14820–14825.
[13] K. Severinov, M. Soushko, A. Goldfarb, V. Nikiforov, Mol. Gen.
Genet. 1994, 244, 120–126.
was repeated by quadruplicate using a concentration of
0.031 mM of the complex, since, as shown in Figure 5, this
concentration optimized mutagenesis in B. subtilis.
As shown in Figure 6, 0.031 mM of [Cu(biaq)Cl2] statistic- [14] K. J. Boor, M. L. Duncan, C. W. Price, J. Biol. Chem. 1995, 270,
20329–20336.
ally increased around eight times the mutation frequency to
[15] E. A. Robleto, H. A. Martin, A. M. Pepper, M. Pedraza-Reyes,
RifR with respect to the untreated strain control. It is worth
Gene Regulation of Sporulation in Bacillus subtilis, in: Bacterial
Spores: Current Research and Applications (Ed.: E. Abel-Santos),
Caister Academic Press, Wymondham, UK, 2012, p. 9–18.
noting that the free ligand biaq, at the same concentration did
not statistically increase its RifR mutation frequency in com-
[16] U. Kempe, T. Dockner, A. Frank, H. Karn, US Patent 4278801,
July 14, 1981.
[17] a) Siemens, XSCAnS (release 2.21) Users Manual, Siemens Ana-
lytical X-ray Instruments Inc., Madison, WI, USA, 1996; b) G. M.
Sheldrick, Acta Crystallogr., Sect. A 2008, 64, 112–122.
parison with the untreated control. Together, these results are
a strong evidence that [Cu(biaq)Cl2] uses the bacterial chromo-
some as a target, producing a damage that should interfere
with replication, although the kind of damage involved in the
interference mechanism does not initiate any SOS response. [18] J. H. Miller, Experiments in Molecular Genetics, Cold Spring
Harbor Laboratory Press, Cold Spring Harbor, NY, 1972.
[19] N. Ramírez-Ramírez, G. Mendoza-Díaz, F. Gutiérrez-Corona, M.
Pedraza-Reyes, J. Biol. Inorg. Chem. 1998, 3, 188–194.
[20] N. Ramírez-Ramírez, G. Mendoza-Díaz, M. Pedraza-Reyes, Bi-
We thus assume that alterations induced by [Cu(biaq)Cl2] on
the rpoB gene, which in turn promote RifR mutagenesis, are
independent of the RecA protein.
oinorg. Chem. Appl. 2003, 1, 25–34.
[21] J. H. Miller, Experiments in Molecular Genetics, Cold Spring
Harbor Laboratory Press, New York, 1972.
[22] M. I. Ramírez, F. X. Castellanos Juárez, R. E. Yasbin, M. Ped-
4 Conclusions
The results presented in this report clearly indicate that the
tested CuII complex featuring a cis-dichlorido group and a tri-
dentate imidazole derivative may have interesting biological
activity, which could allow to design alternative chemothera-
peutic drugs.
raza-Reyes, J. Bacteriol. 2004, 186, 1050–1059.
[23] A. W. Addison, J. N. Rao, J. Reedijk, J. van Rijn, G. C. Ver-
schoor, J. Chem. Soc. Dalton Trans. 1984, 1349.
[24] C. A. Salata, M. T. Youinou, C. J. Burrows, Inorg. Chem. 1991,
30, 3454.
[25] Bacillus subtilis and Other Gram-Positive Bacteria; Biochemistry
Physiology and Molecular Genetics (Ed.: A. L. Sonenshein),
American Society for Microbiology, Washington, DC. 1993.
[26] E. Y. Bivián-Castro, M. G. López, M. Pedraza-Reyes, S. Bernès,
G. Mendoza-Díaz, Bioinorg. Chem. Appl. 2009, DOI:10.1155/
2009/603651.
References
[1] K. J. Oberhausen, R. J. O’Brien, J. F. Richardson, R. M. Bu-
chanan, Inorg. Chim. Acta 1990, 173, 145.
[2] H. Oka, Y. Nakao, S. Suzuki, W. Mori, I. Kinoshita, S. Ooi, A.
Ichimura, Inorg. Chim. Acta 1989, 165, 111.
Received: February 10, 2013
Published Online: May 29, 2013
1460
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Z. Anorg. Allg. Chem. 2013, 1455–1460